Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

被引：0
|
作者：
Stephen K. Tyring
Phoebe Rich
Yayoi Tada
Stefan Beeck
Izabella Messina
Jie Liu
Xiaohong Huang
Stephen Shumack
机构：
[1] University of Texas Health Science Center,Department of Dermatology, McGovern Medical School
[2] Oregon Health and Science University,undefined
[3] Teikyo University School of Medicine,undefined
[4] AbbVie Inc.,undefined
[5] St George Dermatology and Skin Cancer Centre,undefined
来源：
Dermatology and Therapy | 2023年 / 13卷
关键词：
Atopic dermatitis; Interleukin-23; Risankizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：595 / 608
页数：13
相关论文
共 50 条
  • [31] A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled, international, multicenter, study to evaluate the efficacy and safety of rezpegaldesleukin in adults with moderate-to-severe atopic dermatitis
    Gooderham, Melinda
    Lynde, Charles
    Alam, Maryam Shayesteh
    Sadick, Neil
    Rohan, Craig A.
    Werschler, William Philip
    Hebert, Adelaide A.
    Laquer, Vivian T.
    Sauder, Maxwell
    Del Rosso, James Q.
    Rodgers, Timothy
    Tan, Ricardo
    Schleicher, Stephen
    Murrell, Dedee F.
    Fernandez-Penas, Pablo
    Reich, Adam
    Gkalpakiotis, Spyridon
    Ruiz, Juan Ruano
    Wollenberg, Andreas
    Szepietowski, Jacek C.
    Sticherling, Michael
    Weyergraf, Ansgar J.
    Hadzavdic, Suzana Ljubojevic
    Baran, Wojciech
    Vilchez, Trinidad Montero
    Eniko, Telegdy
    Sebastian, Michael
    Chaudhry, Sohail
    Lee, Zachary
    Yu, Danni
    Liu, Yi
    Waltz, Wang
    Gilbert, Jenny
    Elko-Simms, Lucinda M.
    Fanton, Christie
    Jue, Charleen
    Tagliaferri, Mary
    Zalevsky, Jonathan
    Rosmarin, David
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 105 - 107
  • [32] Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
    Silverberg, Jonathan, I
    Pinter, Andreas
    Pulka, Grazyna
    Poulin, Yves
    Bouaziz, Jean-David
    Wollenberg, Andreas
    Murrell, Dedee F.
    Alexis, Andrew
    Lindsey, Lisa
    Ahmad, Faiz
    Piketty, Christophe
    Clucas, Alan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (01) : 173 - 182
  • [33] Effects of cetirizine in dogs with chronic atopic dermatitis: a randomized, double blind, placebo-controlled trial
    Hsiao, Yun-Hsia
    Chen, Charles
    Willemse, Ton
    JOURNAL OF VETERINARY SCIENCE, 2016, 17 (04) : 549 - 553
  • [34] Efficacy of Individualized Homeopathic Medicines in the Treatment of Atopic Dermatitis in Adults: A Double-Blind, Randomized, Placebo-Controlled, Preliminary Trial
    Dey, Samit
    Shaikh, Abdur Rahaman
    Saha, Sangita
    Agrawal, Ekta
    Gautam, Ashish Kumar
    Karuppusamy, Avaranjika
    Sadhukhan, Satarupa
    Dutta, Souvik
    Ali, Sk. Swaif
    Basu, Anamika
    Koley, Munmun
    Saha, Subhranil
    COMPLEMENTARY MEDICINE RESEARCH, 2022, 29 (01) : 17 - 26
  • [35] Outcome of double-blind, placebo-controlled food challenge tests in 107 children with atopic dermatitis
    Niggemann, B
    Sielaff, B
    Beyer, K
    Binder, C
    Wahn, U
    CLINICAL AND EXPERIMENTAL ALLERGY, 1999, 29 (01) : 91 - 96
  • [36] Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial
    Viljanen, M
    Savilahti, E
    Haahtela, T
    Juntunen-Backman, K
    Korpela, R
    Poussa, T
    Tuure, T
    Kuitunen, M
    ALLERGY, 2005, 60 (04) : 494 - 500
  • [37] Efficacy and safety of Soshiho-tang in patients with atopic dermatitis and gastrointestinal disorders Study protocol for a double-blind, randomized, and placebo-controlled clinical trial
    Kang, Su-Jin
    Jo, Eun-Heui
    Yang, Geum-Jin
    Shim, Yu-Hwa
    Hong, Ji-Eun
    Park, Min-Cheol
    MEDICINE, 2019, 98 (18)
  • [38] KM110329 in adult patients with atopic dermatitis: a randomised, double-blind, placebo-controlled, multicentre trial – study protocol
    Chunhoo Cheon
    Sunju Park
    Jeong-Su Park
    So-Mi Oh
    Soobin Jang
    Ho-Yeon Go
    Bo-Hyoung Jang
    Yong-Cheol Shin
    Seong-Gyu Ko
    BMC Complementary and Alternative Medicine, 13
  • [39] Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis
    Blauvelt, Andrew
    Simpson, Eric L.
    Tyring, Stephen K.
    Purcell, Lisa A.
    Shumel, Brad
    Petro, Christopher D.
    Akinlade, Bolanle
    Gadkari, Abhijit
    Eckert, Laurent
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Evans, Robert
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (01) : 158 - +
  • [40] Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
    Guttman-Yassky, Emma
    Brunner, Patrick M.
    Neumann, Avidan U.
    Khattri, Saakshi
    Pavel, Ana B.
    Malik, Kunal
    Singer, Giselle K.
    Baum, Danielle
    Gilleaudeau, Patricia
    Sullivan-Whalen, Mary
    Rose, Sharon
    On, Shelbi Jim
    Li, Xuan
    Fuentes-Duculan, Judilyn
    Estrada, Yeriel
    Garcet, Sandra
    Traidl-Hoffmann, Claudia
    Krueger, James G.
    Lebwohl, Mark G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (05) : 872 - +
12345